Trials / Unknown
UnknownNCT04425772
A Clinical Trial for Azvudine in the Treatment of Novel Coronavirus Pneumonia (COVID-19）
A Randomized,Double Blinded, Double Dummy, Parallel Controlled Clinical Trial for Azvudine in the Treatment of Novel Coronavirus Pneumonia (COVID-19）
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 342 (estimated)
- Sponsor
- Henan Genuine Biotech Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the efficacy and safety of azvudine in treatment of COVID-19
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | FNC+Standard of Care | FNC + Standard of Care according to the to the latest version of the National Health and Medical Commission Diagnostic criteria |
| DRUG | FNC dummy tablet+Standard of Care | FNC dummy tablet+ Standard of Care according to the to the latest version of the National Health and Medical Commission Diagnostic criteria |
Timeline
- Start date
- 2020-06-12
- Primary completion
- 2020-08-12
- Completion
- 2020-08-12
- First posted
- 2020-06-11
- Last updated
- 2020-06-11
Source: ClinicalTrials.gov record NCT04425772. Inclusion in this directory is not an endorsement.